Pediatric Central Nervous System Tumor Overview and Emerging Treatment Considerations

Sudarshawn Damodharan; Diane Puccetti

doi:10.3390/brainsci13071106

Pediatric Central Nervous System Tumor Overview and Emerging Treatment Considerations

Brain Sci. 2023 Jul 21;13(7):1106. doi: 10.3390/brainsci13071106.

Authors

Sudarshawn Damodharan¹, Diane Puccetti¹

Affiliation

¹ Department of Pediatrics, Division of Pediatric Hematology, Oncology and Bone Marrow Transplant, University of Wisconsin School of Medicine & Public Health, Madison, WI 53792, USA.

Abstract

Pediatric central nervous system (CNS) tumors are the most common solid tumor in children, with the majority being glial in origin. These tumors are classified by the World Health Organization (WHO) as either being low grade (WHO grade 1 and 2) or high grade (WHO grade 3 and 4). Our knowledge of the molecular landscape of pediatric brain tumors has advanced over the last decade, which has led to newer categorizations along with an expansion of therapeutic targets and options. In this review, we will give an overview of common CNS tumors seen in children along with a focus on treatment options and future considerations.

Keywords: CNS; molecular; pediatrics; treatment; tumors.

Publication types

Review

Grants and funding

This research received no external funding.